Loading...

Affimed N.V.

AFMDQ•PNK
Healthcare
Biotechnology
$0.00
$0.00(0.00%)
U.S. Market opens in 56h 1m

Affimed N.V. (AFMDQ) Stock Overview

Explore Affimed N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.9K
P/E Ratio-0.00
EPS (TTM)$-5.33
ROE-1.01%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

AFMDQ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Affimed N.V. (AFMDQ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 100.00, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 4.9K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
200.00%
1-Month Change
N/A
3-Month Change
200.000%
6-Month Change
-94.00%
Year-to-Date (YTD) Change
200.000%
1-Year Change
-99.96%
3-Year Change
-100.00%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

https://www.affimed.com
49 621 560030
Gottlieb-Daimler-Straße 2, Mannheim, NaN, 68165

Company Facts

76 Employees
IPO DateSep 12, 2014
CountryDE
Actively Trading

Frequently Asked Questions